Loading investors…
Ranked by rounds participated in, from announcements in Jan 1, 2026 – Oct 4, 2026. Lead counts include only confirmed lead roles.
New companies 17 · Follow-on 0
Stages: Series C+ 6, Series A 4, Series B 4, Undisclosed 2, Growth 1
AusperBio $120M Series CAbcuro $66M Series DInfinimmune $75M Series ANew companies 11 · Follow-on 0
Stages: Series A 4, Series B 3, Series C+ 3, Undisclosed 1
Epicrispr Biotechnologies $90M Series CDraig Therapeutics $65M Series BTriveni Bio $65M Series CNew companies 11 · Follow-on 0
Stages: Series B 5, Undisclosed 3, Series A 2, Series C+ 1
LifeMine Therapeutics $263M Series D+Series EOllin Biosciences $330M Series BSonoThera $125M Series BNew companies 10 · Follow-on 0
Stages: Series A 3, Series B 3, Undisclosed 3, Series C+ 1
Leal Therapeutics $30M Series AKhartis Therapeutics $50M Series BVedana Therapeutics $46M Series ANew companies 10 · Follow-on 0
Stages: Series B 4, Series A 2, Series C+ 2, Seed 1, Undisclosed 1
Leal Therapeutics $30M Series AAmplifica Holdings Group $26M Series BInduPro $77M Series BNew companies 10 · Follow-on 0
Stages: Series A 4, Series B 3, Series C+ 3
Leal Therapeutics $30M Series AAccro Bioscience $50M Series CVivacta Biotechnology $50M Series A+New companies 8 · Follow-on 0
Stages: Seed 6, Pre-seed 1, Series A 1
Fermeate $2M SeedTippingPoint Biosciences $4.5M SeedCauldron Ferm $13.3M Series A2New companies 7 · Follow-on 0
Stages: Series C+ 3, Series A 2, Series B 2
Abcuro $66M Series DEpicrispr Biotechnologies $90M Series CQuantHealth $45M Series BNew companies 7 · Follow-on 0
Stages: Series C+ 5, Series B 2
Epicrispr Biotechnologies $90M Series CAdvanCell $315M Series DAllotera Therapeutics $35M Series CNew companies 7 · Follow-on 0
Stages: Series B 3, Series C+ 2, Series A 1, Undisclosed 1
LifeMine Therapeutics $263M Series D+Series EContraline $92.5M Series BIsomorphic Labs $2.1B Series BNew companies 5 · Follow-on 1
Stages: Series A 2, Series C+ 2, Series B 1, Undisclosed 1
AusperBio $120M Series CVivacta Biotechnology $50M Series A+Vivatides Therapeutics $54M Series ANew companies 6 · Follow-on 0
Stages: Seed 2, Series A 1, Series B 1, Series C+ 1, Undisclosed 1
Bionyra Pharma $165M Series AIngenix €13M Seed+P2 Science $23M UndisclosedNew companies 5 · Follow-on 0
Stages: Undisclosed 3, Series A 1, Series B 1
ProFound Therapeutics $35M StrategicLeyden Laboratories €40M Series BKanvas Biosciences $48M Series ANew companies 5 · Follow-on 0
Stages: Seed 2, Series C+ 2, Series A 1
Transfyr $25M SeedChai Discovery $400M Series CWaypoint Bio $20M Series ANew companies 5 · Follow-on 0
Stages: Series A 2, Series C+ 2, Series B 1
Abcuro $66M Series DKhartis Therapeutics $50M Series BSlate Medicines $130M Series ANew companies 5 · Follow-on 0
Stages: Series B 3, Series C+ 2
Abcuro $66M Series DSidewinder Therapeutics $137M Series BAmbrosia Biosciences $100M Series BNew companies 4 · Follow-on 1
Stages: Series A 2, Series B 2, Series C+ 1
InduPro $77M Series BSonoThera $125M Series BAdcendo $75M Series CNew companies 5 · Follow-on 0
Stages: Series B 4, Series A 1
Vaderis Therapeutics $152M Series BRQ Bio $115M Series ATenpoint Therapeutics $235M Series BNew companies 5 · Follow-on 0
Stages: Series B 3, Series A 1, Series C+ 1
Vaderis Therapeutics $152M Series BOllin Biosciences $330M Series BAdcendo $75M Series CNew companies 5 · Follow-on 0
Stages: Series B 3, Series C+ 1, Undisclosed 1
LifeMine Therapeutics $263M Series D+Series ECity Therapeutics $99.5M Series BContraline $92.5M Series BNew companies 5 · Follow-on 0
Stages: Seed 3, Series A 1, Series C+ 1
Vivid Dx $15M SeedMirae $5.4M SeedMoa Technology £22.2M Series CNew companies 5 · Follow-on 0
Stages: Series A 2, Series B 2, Series C+ 1
Crystalys Therapeutics $130M Series BRQ Bio $115M Series ASidewinder Therapeutics $137M Series BNew companies 4 · Follow-on 1
Stages: Series A 3, Series B 2
Crystalys Therapeutics $130M Series BDraig Therapeutics $65M Series BPoplar Therapeutics $45M Series A+New companies 5 · Follow-on 0
Stages: Seed 2, Series A 2, Series C+ 1
Brenus Pharma €11M Series ALys Therapeutics >€25M SeedAdcendo $75M Series CNew companies 5 · Follow-on 0
Stages: Series A 3, Series B 1, Series C+ 1
RQ Bio $115M Series ACellCentric $220M Series DSlate Medicines $130M Series ANew companies 5 · Follow-on 0
Stages: Series B 2, Undisclosed 2, Seed 1
TRIMTECH Therapeutics $47M Seed+SonoThera $125M Series BTRex Bio $50M UndisclosedNew companies 5 · Follow-on 0
Stages: Seed 2, Series A 1, Series B 1, Undisclosed 1
TRIMTECH Therapeutics $47M Seed+Crossbow Therapeutics $77M Series BTRex Bio $50M UndisclosedNew companies 5 · Follow-on 0
Stages: Series C+ 2, Seed 1, Series A 1, Undisclosed 1
Pramaana Labs $27M SeedNovellia $18M Series AFolly Undisclosed Follow-OnNew companies 5 · Follow-on 0
Stages: Series B 3, Undisclosed 2
SonoThera $125M Series BFull-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPONew companies 5 · Follow-on 0
Stages: Seed 3, Series A 2
Century Health $5M SeedKanvas Biosciences $48M Series AAxoft $55M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.